Preventive efficacy of butyrate enemas and oral administration of Clostridium butyricum M588 in dextran sodium sulfate-induced colitis in rats
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Butyrate enemas have been reported to be effective in ulcerative colitis. However, long-term use is difficult because of the troublesome procedure and the unpleasant smell. We therefore investigated the effects of the oral administration of Clostridium butyricum M588 (CBM588), an enterobacterium producing butyrate, in dextran sodium sulfate (DSS)-induced colitis in rats. First, we confirmed the effects of pre-treatment with a butyrate enema on DSS colitis. We then studied the efficacy of oral administration of CBM588 which was started 1 week prior to the induction of DSS colitis. In the CBM588 group, the ulcer index and myeloperoxidase (MPO) activity in the distal colon were significantly lower than in the control group. Proliferating cell nuclear antigen (PCNA) immuno-positive cells were increased around the ulcer in the CBM588 group. In regard to the contents of the cecum and colon, the proportions of Lactobacillus and Eubacterium were increased in the cecum in the CBM588 group. Further, there were significant increases of n-butyrate, propionate, and acetate concentrations in the cecum in the CBM588 group. These results indicated that the oral administration of CBM588 alleviated DSS-induced colitis, and may be useful instead of butyrate enema.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like butyrate, propionate is also a short chain fatty acid that has been shown to have an anticancer effect: previous in vivo studies assessing CBM588 have demonstrated upregulation of this metabolite27,28.”
From Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial (2022) · cites this paper as [28]
In the citing paper
“previous in vivo studies assessing CBM588 have demonstrated upregulation of this metabolite27,28.”
From Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial (2022) · cites this paper as [28]
Citations
Cites
Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity
Krawisz, J. E., Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90202-6 · Cited by 1,758
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis
Scheppach, W., Sommer, H., Kirchner, T., Paganelli, G.-M., Bartram, P., Christl, S., Richter, F., Dusel, G., & Kasper, H. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91094-k · Cited by 741
THE COLONIC EPITHELIUM IN ULCERATIVE COLITIS: AN ENERGY-DEFICIENCY DISEASE?
Roediger, W. E. W. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91934-0 · Cited by 719
Sakata, T. (1987) · British Journal of Nutrition · doi:10.1079/bjn19870073 · Cited by 653
Butyrate production from dietary fibre and protection against large bowel cancer in a rat model.
McIntyre, A., Gibson, P. R., & Young, G. P. (1993) · Gut · doi:10.1136/gut.34.3.386 · Cited by 555
Hague, A., Elder, D. J. E., Hicks, D. J., & Paraskeva, C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600322 · Cited by 412
Role of short-chain fatty acids in the prevention of colorectal cancer
Scheppach, W., Bartram, H. P., & Richter, F. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00165-f · Cited by 349
Stimulation of Intestinal Mucosal Growth with Intracolonic Infusion of Short‐Chain Fatty Acids
Kripke, S. A., Fox, A. D., Berman, J. M., Settle, R. G., & Rombeau, J. L. (1989) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607189013002109 · Cited by 336
Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.
Butzner, J. D., Parmar, R., Bell, C. J., & Dalal, V (1996) · Gut · doi:10.1136/gut.38.4.568 · Cited by 213
Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
Steinhart, A. H., Brzezinski, A., & Baker, J. (1994) · PubMed · Cited by 137
Cited by
Tedelind, S., Westberg, F., Kjerrulf, M., & Vidal, A. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i20.2826 · Cited by 853
From the gut to the peripheral tissues: the multiple effects of butyrate
Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., & Van Immerseel, F. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000247 · Cited by 806
“Many studies have demonstrated that delivery of butyrate through local enema or diet results in a protective or therapeutic effect against inflammatory bowel diseases((170,171)).”
Dizman, N., Meza, L., Bergerot, P., Alcantara, M., Dorff, T., Lyou, Y., Frankel, P., Cui, Y., Mira, V., Llamas, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01694-6 · Cited by 515
Larrosa, M., González-Sarrías, A., Yáñez-Gascón, M. J., Selma, M. V., Azorín-Ortuño, M., Toti, S., Tomás-Barberán, F., Dolara, P., & Espín, J. C. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.04.012 · Cited by 504
“In fact, it has also been confirmed that butyrate has anti-inflammatory actions through its suppression of the inflammatory cytokine cascade [35].”
BackgroundEnhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate†
Lewis, K., Lutgendorff, F., Phan, V., Söderholm, J. D., Sherman, P. M., & McKay, D. M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21177 · Cited by 335
Endo, H., Niioka, M., Kobayashi, N., Tanaka, M., & Watanabe, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063388 · Cited by 336
“butyricum is used as a probiotic for treating and preventing non-antimicrobialinduced diarrhea, antimicrobial-associated diarrhea, and constipation in humans [12,13].”
BackgroundThe microbiome and regulation of mucosal immunity
McDermott, A. J., & Huffnagle, G. B. (2014) · Immunology · doi:10.1111/imm.12231 · Cited by 334
Recharla, N., Geesala, R., & Shi, X.-Z. (2023) · Nutrients · doi:10.3390/nu15102275 · Cited by 256
Zhang, Q., Wu, Y., Wang, J., Wu, G., Long, W., Xue, Z., Wang, L., Zhang, X., Pang, X., Zhao, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep27572 · Cited by 233
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
Hu, H., Lin, A., Kong, M., Yao, X., Yin, M., Xia, H., Ma, J., & Liu, H. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-019-01649-8 · Cited by 208
Chen, L., Xu, W., Lee, A., He, J., Huang, B., Zheng, W., Su, T., Lai, S., Long, Y., Chu, H., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.08.028 · Cited by 205
“In addition to being a major energy source for colonocytes, butyrate has been shown to promotemucosal homeostasis likely through beneficial effects on innate and adaptive immune cells as well as epithelial barrier function [16,17].”
BackgroundMiyaoka, T., Kanayama, M., Wake, R., Hashioka, S., Hayashida, M., Nagahama, M., Okazaki, S., Yamashita, S., Miura, S., Miki, H., et al. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000299 · Cited by 186
Microbiota-derived lactate accelerates colon epithelial cell turnover in starvation-refed mice
Okada, T., Fukuda, S., Hase, K., Nishiumi, S., Izumi, Y., Yoshida, M., Hagiwara, T., Kawashima, R., Yamazaki, M., Oshio, T., et al. (2013) · Nature Communications · doi:10.1038/ncomms2668 · Cited by 167
Kanai, T., Mikami, Y., & Hayashi, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1084-x · Cited by 159
Takahashi, M., Taguchi, H., Yamaguchi, H., Osaki, T., Komatsu, A., & Kamiya, S. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.03.010 · Cited by 159
Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’
Damaskos, D., & Kolios, G. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03096.x · Cited by 151
Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease
Couto, M. R., Gonçalves, P., Magro, F., & Martel, F. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104947 · Cited by 166
Prospects for clinical applications of butyrate-producing bacteria
Zhu, L., Zhang, Y., Huang, H.-H., & Lin, J. (2021) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v10.i5.84 · Cited by 152
D’Souza, W. N., Douangpanya, J., Mu, S., Jaeckel, P., Zhang, M., Maxwell, J. R., Rottman, J. B., Labitzke, K., Willee, A., Beckmann, H., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180190 · Cited by 132
Physiology and Sporulation in Clostridium
Dürre, P. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbs-0010-2012 · Cited by 185
Gaudier, E. A., Michel, C., Segain, J., Cherbut, C., & Hoebler, C. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2753 · Cited by 141
Liao, X., Ma, G., Cai, J., Fu, Y. W., Yan, X., Wei, X. B., & Zhang, R. J. (2015) · Poultry Science · doi:10.3382/ps/pev038 · Cited by 120
“2Corresponding author: zhangrj621@126.com et al., 1973; Okamoto et al., 2000; Kong et al., 2011).”
Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice
Herías, M. V., Koninkx, J. F. J. G., Vos, J. G., Veld, J. H. J. H. I., & van Dijk, J. E. (2005) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2004.11.032 · Cited by 113
Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice
Liu, M., Xie, W., Wan, X., & Deng, T. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106862 · Cited by 118
Ohkawara, S., Furuya, H., Nagashima, K., Asanuma, N., & Hino, T. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2878 · Cited by 122
“Recently, administration of this bacterium was shown to suppress chemically induced aberrant crypt foci (ACF),(4) putative preneoplastic lesions, in the rat colon (16) and experimental colitis in rats (17,18).”
BackgroundUronis, J. M., Arthur, J. C., Keku, T., Fodor, A., Carroll, I. M., Cruz, M. L., Appleyard, C. B., & Jobin, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21366 · Cited by 105
“While the mechanism underlying the therapeutic effect of VSL#3 is currently unknown, it has been speculated that the beneficial activities of probiotics are propagated through a wide range of effects including inhibition of bacterial translocation, release of bacteriocidin and lactic acid, production of butyric acid,…”
BackgroundVenema, K. (2011) · International Dairy Journal · doi:10.1016/j.idairyj.2011.10.011 · Cited by 111
Woo, T., Oka, K., Takahashi, M., Hojo, F., Osaki, T., Hanawa, T., Kurata, S., Yonezawa, H., & Kamiya, S. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.033423-0 · Cited by 104
“CBM588 has shown beneficial effects on colonic inflammation in a rat dextran sulphate colitis model, reportedly by increased production of SCFAs in the colon (Okamoto et al., 2000) and enhancement of host Lactobacillus species (Ichikawa et al., 1999).”
BackgroundSeo, M., Inoue, I., Tanaka, M., Matsuda, N., Nakano, T., Awata, T., Katayama, S., Alpers, D., & Komoda, T. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2879-3 · Cited by 99
“There are many reports suggesting that SCFAs have potential beneficial effects; in particular, butyrate has a proliferative effect on intestinal mucosal cells [11] and antiinflammatory effects [12, 13].”
BackgroundSHINNOH, M., HORINAKA, M., YASUDA, T., YOSHIKAWA, S., MORITA, M., YAMADA, T., MIKI, T., & SAKAI, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1790 · Cited by 92
Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse.
Madsen, K. L. (2001) · PubMed · Cited by 89
Hayashi, A., Nagao‐Kitamoto, H., Kitamoto, S., Kim, C. H., & Kamada, N. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000353 · Cited by 95
“is reported that CBM588 produces not only butyrate but also other SCFA such as acetate and propionate (53).”
BackgroundImase, K., Takahashi, M., Tanaka, A., Tokunaga, K., Sugano, H., Tanaka, M., Ishida, H., Kamiya, S., & Takahashi, S. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00026.x · Cited by 81
Shang, H., Sun, J. T., & Chen, Y. Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154373 · Cited by 88
Immunomodulating Activity of Plant Polysaccharide Structures
Yamada, H., & Kiyohara, H. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00125-2 · Cited by 77
Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy
Shimbo, I. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i47.7520 · Cited by 75
Zhao, H., Jia, L., Yan, Q., Deng, Q., & Wei, B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.561061 · Cited by 69
“butyricum M588 leads to high production of butyrate and protects against dextran sodium sulfateinduced colitis in rats (Okamoto et al., 2000).”
BackgroundSasaki, K., Inoue, J., Sasaki, D., Hoshi, N., Shirai, T., Fukuda, I., Azuma, T., Kondo, A., & Osawa, R. (2019) · Biotechnology Journal · doi:10.1002/biot.201800555 · Cited by 70
Geirnaert, A., Wang, J., Tinck, M., Steyaert, A., Van den Abbeele, P., Eeckhaut, V., Vilchez-Vargas, R., Falony, G., Laukens, D., De Vos, M., et al. (2015) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiv054 · Cited by 63
“…general increase in butyrate production after treatment with butyrate-producing Clostridium tyrobutyricum, Butyrivibrio fibrisolvens or Eubacterium limosum (Okamoto et al. 2000; Asanuma, Kawato and Hino 2001; Ohkawara et al. 2005; Kanauchi et al. 2006; Possemiers et al. 2008; Hudcovic et al. 2012).”
BackgroundLiao, X., Wu, R., Ma, G., Zhao, L., Zheng, Z., & Zhang, R. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0035-0 · Cited by 64
Gaining Insight into Microbial Physiology in the Large Intestine: A Special Role for Stable Isotopes
de Graaf, A. A., & Venema, K. (2007) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(07)53002-x · Cited by 71
Hudcovic, T., Kolinska, J., Klepetar, J., Stepankova, R., Řezanka, T., Šrůtková, D., Schwarzer, M., Erban, V., Du, Z., Wells, J. M., et al. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04498.x · Cited by 64
Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells
Säemann, M. D., Parolini, O., Böhmig, G. A., Kelemen, P., Krieger, P.-M., Neumüller, J., Knarr, K., Kammlander, W., Hörl, W. H., Diakos, C., et al. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.2.238 · Cited by 58
Liu, M., Xie, W., Wan, X., & Deng, T. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9138 · Cited by 67
“CB is a strictly anaerobic gram‐positive bacterium, which produces acetic and butyric acid, two impor‐ tant components of SCFAs synthetized by gut microbiota (27).”
BackgroundPrebiotics and human health: The state-of-the-art and future perspectives
Conway, P. L. (2001) · Näringsforskning · doi:10.3402/fnr.v45i0.1784 · Cited by 57
Diet, Microbiome, and the Intestinal Epithelium: An Essential Triumvirate?
Guzman, J. R., Conlin, V. S., & Jobin, C. (2013) · BioMed Research International · doi:10.1155/2013/425146 · Cited by 70
“We will discuss emerging studies into the molecular effects of short-chain fatty acids, their production by bacteria through intake of prebiotic fiber and resistant starches, and emerging details on probiotics and their mechanisms of action.”
BackgroundClostridium butyricum TO-A Culture Supernatant Downregulates TLR4 in Human Colonic Epithelial Cells
Isono, A., Katsuno, T., Satô, T., Nakagawa, T., Kato, Y., Sato, N., Seo, G., Suzuki, Y., & Saitō, Y. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9593-3 · Cited by 52
“However, its long-term use is difficult because of the troublesome procedure required and the unpleasant smell [ 45 ].”
BackgroundMar, J. S., Nagalingam, N. A., Song, Y., Onizawa, M., Lee, J. W., & Lynch, S. V. (2014) · Gut Microbes · doi:10.4161/gmic.32147 · Cited by 57
Goto, H., Takemura, N., Ogasawara, T., Sasajima, N., Watanabe, J., Ito, H., Morita, T., & Sonoyama, K. (2010) · Journal of Nutrition · doi:10.3945/jn.110.125948 · Cited by 50
“Indeed, the efficacy of butyrate enemas in colitis has been reported in experimental (45,46) and clinical studies (47–50).”
BackgroundSteppe, M., Nieuwerburgh, F. V., Vercauteren, G., Boyen, F., Eeckhaut, V., Deforce, D. L. D., Haesebrouck, F., Ducatelle, R., & Immerseel, F. V. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.06.024 · Cited by 60
Induction of Peroxisomes by Butyrate-Producing Probiotics
Weng, H., Endo, K., Li, J., Kito, N., & Iwai, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117851 · Cited by 48
“Therefore, as a gentler method than tributyrin or 4-PBA administration, we used both CBM and inulin treatment to increase the intrinsic production of butyrate in the colon and butyrate concentrations in the blood [14, 26], and thereby promote butyrate availability in the liver for activation of the Fgf21-PPARα pathway.”
MethodTakahashi, M., ΜcCartney, Ε., Knox, A., Francesch, M., Oka, K., Wada, K., Ideno, M., Uno, K., Kozłowski, K., Jankowski, J., et al. (2018) · Animal Science Journal · doi:10.1111/asj.13006 · Cited by 46
Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice
Yang, X., Wang, Z., Niu, J., Zhai, R., Xue, X., Wu, G. G., Fang, Y., Meng, G., Yuan, H., Zhao, L., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01507-z · Cited by 51
Sawada, Y., Kawaratani, H., Kubo, T., Fujinaga, Y., Furukawa, M., Saikawa, S., Sato, S., Seki, K., Takaya, H., Okura, Y., et al. (2018) · Hepatology Research · doi:10.1111/hepr.13281 · Cited by 36
Pu, W., Zhang, H., Zhang, T., Guo, X., Wang, X., & Tang, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1004756 · Cited by 36
“Frontiers in Immunology 09 CB is an obligate anaerobe characterized by the production of butyric acid, which directly provides energy for colon cells and alleviates the symptoms of inflammation (69).”
BackgroundLu, H., Zhang, C., Qian, G., Hu, X., Zhang, H., Chen, C., Liang, W., Gao, H., Yang, Y., & Li, L. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-359 · Cited by 34
“CBM588 (Clostridium butyricum 588 strain MIYA-BM tablets; Miyarisan Pharmaceutical, Tokyo, Japan) prevents antibiotic-associated diarrhea [10] and has antiinflammatory effects in the colon as a result of butyric acid production [11].”
BackgroundProtection Mechanism of Clostridium butyricum against Salmonella Enteritidis Infection in Broilers
Zhao, X., Yang, J., Wang, L., Lin, H., & Sun, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01523 · Cited by 29
Genome sequencing of Clostridium butyricum DKU-01, isolated from infant feces
Mo, S., Kim, B. S., Yun, S.-J., Lee, J.-J., Yoon, S.-H., & Oh, C. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0055-3 · Cited by 27
“butyricum has been used as a probiotic in Asia for treating and preventing nonantimicrobial induced diarrhea, antimicrobial-associated diarrhea, and constipation in humans [4,5].”
BackgroundSantos, A. F. P., Cervantes, L. C. C., Panahipour, L., Souza, F. Á., & Gruber, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911006 · Cited by 28
“For instance, oral administration of Clostridium butyricum M588, an enterobacterium producing butyrate, reduced dextran sodium sulfateinduced colitis in rats [17].”
BackgroundXie, Y., Zhou, L., Yao, X., & Li, Y. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.021 · Cited by 25
Intermittent fasting prompted recovery from dextran sulfate sodium-induced colitis in mice
Okada, T., Otsubo, T., Hagiwara, T., Inazuka, F., Kobayashi, E., Fukuda, S., Inoue, T., Higuchi, K., Kawamura, Y. I., & Dohi, T. (2017) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.17-9 · Cited by 21
Probiotics and Iletis: Could augmentation of TNF/NF-κB activity be the answer?
Jobin, C. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12485 · Cited by 20
Control of mucosal polymicrobial populations by innate immunity
Summers, K. L., & Huffnagle, G. B. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01347.x · Cited by 18
“Butyrate has been used to treat colitis and can reverse the increased mucosal permeability in this disease (Okamoto et al., 2000; Venkatraman et al., 2000).”
BackgroundCazzaniga, M., Cardinali, M., Pierro, F. D., Zonzini, G. B., Palazzi, C. M., Gregoretti, A., Zerbinati, N., Guasti, L., & Bertuccioli, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042306 · Cited by 15
“At the same time, there is an observed increase in proliferating cells (PCNA) around lesions, along with simultaneous higher levels of Lactobacillus and Eubacterium, as well as increased levels of butyrate, propionate, and acetate at the cecal level [51].”
BackgroundYang, Y. P., Guo, Y., Ding, Y., Li, J., Liang, L., Shi, D., Li, X., & Ma, Y. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102234 · Cited by 19
“39 More-over, administration of CBM588 increased the chemokines CXCL9 and CXCL10, who serve as important mediators of cytotoxic T cell and T helper 1 cell recruitment.”
Parhar, K. K. S., Baer, K. A., Parker, K., & Ropeleski, M. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2005 · Cited by 13
“Furthermore, the absence of lumenal sources of butyrate leads to worsened mucosal damage in the dextran sulfate sodium (DSS) model of colitis (45, 46, 61).”
BackgroundFan, S., Tu, Z., Zhang, Z., Fu, L. H., Shen, N., & Xiao, X. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c12022 · Cited by 17
Physiology and Sporulation in Clostridium
Dürre, P. (2016) · ASM Press eBooks · doi:10.1128/9781555819323.ch15 · Cited by 16
Švejstil, R., Plachý, V., Joch, M., Salmonová, H. Š., Dušková, D., Hautekiet, V., & Vlková, E. (2019) · Czech Journal of Animal Science · doi:10.17221/143/2019-cjas · Cited by 9
Probiotics in the treatment of Helicobacter pylori infection: reality and perspective
ISAEVA, G., & ISAEVA, R. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.21.02926-0 · Cited by 7
Bertuccioli, A., Cardinali, M., Zonzini, G. B., Neri, M., Palazzi, C. M., Gregoretti, A., Cazzaniga, M., & Pierro, F. D. (2023) · Microbiology Research · doi:10.3390/microbiolres14020036 · Cited by 10
“Evaluations carried out on the animal model have demonstrated a high colonizing power and the ability to produce significant levels of butyric acid [61,62].”
BackgroundChange in gut histomorphology and microbiota in Chinese strip‐necked turtle hatchlings
Hong, M., Li, N., Liang, L., Zhang, J., Wang, D., Shi, H., & Ding, L. (2021) · Aquaculture Research · doi:10.1111/are.15119 · Cited by 6
Harnessing Probiotics to Combat Candidiasis: Mechanisms, Evidence, and Future Directions
Wright, E., Valand, N., & Girija, U. V. (2025) · Journal of Fungi · doi:10.3390/jof11110779 · Cited by 5
“In a rat model of dextran sodium sulphate-induced colitis, C. butyricum CBM 588 notably increased levels of butyric acid in the cecum, indicating that it actively produces high levels of butyric acid in vivo [142].”
Characterisation of potential anti-inflammatory next-generation probiotics resistant to bisphenol A
López‐Moreno, A., Carbonne, C., Kropp, C., Ríos-Covián, D., Pepke, F., Langella, P., Aguilera, J., & Martín, R. (2017) · Beneficial Microbes · doi:10.1163/18762891-bja00041 · Cited by 5
Xie, Y., Zhou, L., Li, H., & Li, Y. (2021) · Current Microbiology · doi:10.1007/s00284-021-02392-1 · Cited by 4
Dai, M., Wu, J., Ji, Z., Chen, P., Yang, C., Luo, J., Shan, P., & Xu, M. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.14401 · Cited by 6
Yan, Y., Dong, L., Xu, J., Zhang, Z., Jia, P., Zhang, J., Chen, W., & Gao, W. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487978 · Cited by 3
Mechanisms of microbial interactions between probiotic microorganisms and Helicobacter pylori
Isaeva, G. S., & Isaeva, R. A. (2023) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2023.3.225-238 · Cited by 2
The 13C-Butyrate Breath Test: a New Non-Invasive Method for Assessing Colitis in a Murine Model
Endo, M., Oikawa, T., Hoshino, T., Hatori, T., Matsumoto, T., & Hanawa, T. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13121fp · Cited by 2
Oka, K., ΜcCartney, Ε., Ariyoshi, T., Kudo, H., Vilà, B., de Jong, L., Kozłowski, K., Jankowski, J., Morgan, S., Kruger, C. L., et al. (2019) · Toxicology Research and Application · doi:10.1177/2397847319826955 · Cited by 2
Bajka, B. H. (2008) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 4
Non‐Lactic Acid Bacteria as Probiotics and their Functional Roles
Ramos, C. L., Esteves, E. A., de Miranda, N. M. Z., Moreno, L. G., & Schwan, R. F. (2022) · Wiley eBooks · doi:10.1002/9781119702160.ch4 · Cited by 3
Huang, Y. S., Sun, Y., Dong, Y., Gai, Z., Gong, X., Xia, Q., & Han, M. (2025) · Food Bioengineering · doi:10.1002/fbe2.70038 · Cited by 2
Impact of Fiber on Gastrointestinal Microbiota
Venema, K. (2010) · Wiley eBooks · doi:10.1002/9780470958186.ch6 · Cited by 2
Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in micePreprint
Yang, X., Wang, Z., Niu, J., Zhai, R., Xue, X., Wu, G. G., Meng, G., Yuan, H., Zhao, L., & Zhang, C. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.05.494898 · Cited by 1
“5-1%) when administered via drinking 82 water in mice [18-20].”
MethodUse of probiotics in inflammatory bowel disease
Sasaki, M., Andoh, A., Tsujikawa, T., & Fujiyama, Y. (2003) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.56.849
Self-citationYang, X., Wang, Z., Niu, J., Zhai, R., Xue, X., Wu, G. G., Fang, Y., Meng, G., Yuan, H., Zhao, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619005
Kim, M.-J., Kim, Y. L., Lee, S. H., Shin, J. S., Kim, S. K., Kim, S. A., Jo, I. G., Jo, G. H., Han, S., Bae, K. D., et al. (2025) · Animals · doi:10.3390/ani15192785
“…of C. butyricum in immune regulation and in-Animals flammation were not directly investigated in the present study, previous studies have reported that C. butyricum exhibits anti-inflammatory and immunomodulatory effects by regulating cytokine production and immune cell differentiation [43,44].”
Nutritional significance of short-chain fatty acids
Karadağ, M. G., Tuğ, T. A., Ağagündüz, D., & Özoğul, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33296-8.00005-8
Schönherr-Hellec, S. (2017) · theses.fr (ABES) · doi:10.70675/e404b5bdz72e8z4530z8638ze08f4b2f41f8
Probiotics and the Colon Therapeutic and Prophylactic Uses
Borody, T. J., & Conway, P. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-314-9_10
Metadata
- Authors
- Okamoto, T., Sasaki, M., Tsujikawa, T., Fujiyama, Y., Bamba, T., & Kusunoki, M.
- Affiliations
- Shiga University of Medical Science (JP)
- Miyarisan Pharmaceutical Co., Ltd. (Japan) (JP)
- Venue
- Journal of Gastroenterology
- Published
- 2000-05-08
- Volume
- 35
- Issue
- 5
- Pages
- 341-346
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2023882748
- Cited by
- 91
- References
- 16
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 4 · 2013: 7
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- DSS-induced colitis, ulcerative colitis, oral administration, short-chain fatty acids, butyrate, Lactobacillus, Eubacterium, myeloperoxidase, proliferating cell nuclear antigen, cecal microbiota, prophylaxis
- MeSH terms
- Acetates, Administration, Oral, Animals, Butyrates, Clostridium, Colitis, Ulcerative, Enema, Male, Peroxidase, Propionates, Dextran Sulfate, Rats, Sprague-Dawley, Proliferating Cell Nuclear Antigen, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.